IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
Dutch Phase 1/2a biotech developing gamma-delta T cell therapies for cancer.
Industry: Health Care
Latest Trade: $3.04 +0.15 (+5.2%)
First Day Return: -4.7%
Return from IPO: -80.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/02/2021 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.7 |
Deal Size ($mm) | $101 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/24/2021 |
Offer Price | $15.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.7 |
Deal Size ($mm) | $101 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Utrecht, Netherlands |
Founded | 2016 |
Employees | 31 |
Website www.lavatherapeutics.com |